In vivo anti-tumor activity of high-dose parenteral ascorbic acid is mediated primarily via cofactor activity, not via oxidative stress.
Talia Akram, Rebecca A. Luchtel, Vinay Dubey, Soma Seal, Ritesh Kumar Aggarwal, Hiroaki Sai, Niraj Konchady Shenoy
This study shows that high-dose parenteral ascorbic acid's anti-tumor effect in vivo is mainly due to cofactor activity, not oxidative stress, using mouse tumor models.
bioRxiv · May 21, 2025 · PreprintCancer Biology